Vol. 7 (10) pp. 667-681 DOI: 10.21474/IJAR01/9879

EFFICACY OF DUODENAL SWITCH OPERATION IN THE MANAGEMENT OF DIABETES IN MORBIDLY OBESE PATIENTS.

, , , and
16 Downloads 84 Views
Crossref

Download Full Paper (PDF)

Abstract

Background: Loop duodenal switch with sleeve gastrectomy is reported to be associated with accepted rates of diabetes remission in obese patients suffering from type II diabetes. We conducted this study to assess the metabolic outcomes of this operation on obese diabetic patients. Study type: Prospective longitudinal cohort study. Patients and methods: Twenty-five cases were included in the study with mean BMI of 61.15 kg/m2. All cases underwent open loop duodenal switch with sleeve gastrectomy. Patients were followed for up after operation for diabetic and metabolic changes. Results: The mean age of the included cases was 34.16 years. Patient weight and BMI were significantly decreased at follow up (p < 0.001). Lipid profile showed a marvelous improvement compared to baseline levels preoperatively. Blood glucose and HbA1c levels were significantly improved (p < 0.001). No significant changes were detected regarding bilirubin or calcium levels. Diabetes full remission was detected in 12 cases (48%) and 8 cases (32%) at 1 and 2 years respectively whereas diabetic control was found 4 cases (16%) at the previously mentioned follow up visits. Regarding complications, GERD was detected in 2 cases (8%) while leakage and intestinal obstruction were detected in one case (4%) for each complication. Conclusion: Based on the results of our study, it is evident that loop duodenal switch with sleeve gastrectomy is effective surgical method in the management of diabetes in obese individuals with accepted morbidity and mortality rates.

Keywords

How to Cite This Article

Atif Mohamed Abd El -Latif, Yasser Ali Elsayed, Tamer Youssef mohamed, Waleed ahmed gado and Mohamed Hafez. (2019); EFFICACY OF DUODENAL SWITCH OPERATION IN THE MANAGEMENT OF DIABETES IN MORBIDLY OBESE PATIENTS., International Journal of Advanced Research (IJAR), 7 (10), 667-681, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/9879

Corresponding Author

mohamed hafez hafez
mansoura medical school

Article Analytics

References

  1. Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., and Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care 2009, 32 (1), 193-203.
  2. Buchwald H., Estok R., Fahrbach K., Banel D., Jensen M.D., Pories W.J., Bantle J.P., and Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. The American journal of medicine 2009, 122 (3), 248-256. e5.
  3. Schauer P.R., Kashyap S.R., Wolski K., Brethauer S.A., Kirwan J.P., Pothier C.E., Thomas S., Abood B., Nissen S.E., and Bhatt D.L. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. New England Journal of Medicine 2012, 366 (17), 1567-1576.
  4. Shimizu H., Timratana P., Schauer P.R., and Rogula T. Review of metabolic surgery for type 2 diabetes in patients with a BMI< 35 kg/m 2. Journal of obesity 2012, 2012.
  5. Cohen R., Caravatto P.P., and Petry T. Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of< 35 kg/m 2: A Surgeon?s Perspective. Obesity surgery 2013, 23 (6), 809-818.
  6. Huang C.K., Tai C.-M., Chang P.-C., Malapan K., Tsai C.-C., and Yolsuriyanwong K. Loop duodenojejunal bypass with sleeve gastrectomy: comparative study with Roux-en-Y gastric bypass in type 2 diabetic patients with a BMI< 35 kg/m 2, first year results. Obesity surgery 2016, 26 (10), 2291-2301.
  7. S?nchez-Pernaute A., Herrera M.A.R., P?rez-Aguirre E., P?rez J.C.G., Cabrerizo L., Valladares L.D., Fern?ndez C., Talavera P., and Torres A. Proximal duodenal?ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obesity surgery 2007, 17 (12), 1614-1618.
  8. Kim J., Azagury D., Eisenberg D., DeMaria E., and Campos G.M. ASMBS position statement on prevention, detection, and treatment of gastrointestinal leak after gastric bypass and sleeve gastrectomy, including the roles of imaging, surgical exploration, and nonoperative management. Surgery for Obesity and Related Diseases 2015, 11 (4), 739-748.
  9. Geubbels N., Lijftogt N., Fiocco M., van Leersum N., Wouters M., and de Brauw L. Meta‐analysis of internal herniation after gastric bypass surgery. British Journal of Surgery 2015, 102 (5), 451-460.
  10. Rubino F., Forgione A., Cummings D.E., Vix M., Gnuli D., Mingrone G., Castagneto M., and Marescaux J. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Annals of surgery 2006, 244 (5), 741.
  11. Drucker D.J. The role of gut hormones in glucose homeostasis. The Journal of clinical investigation 2007, 117 (1), 24-32.
  12. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care 2004, 27 (5), 1047-1053.
  13. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., Zieve F.J., Marks J., Davis S.N., and Hayward R. Glucose control and vascular complications in veterans with type 2 diabetes. New England Journal of Medicine 2009, 360 (2), 129-139.
  14. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. Jama 2004, 291 (3), 335-342.
  15. Rubino F., Schauer P.R., Kaplan L.M., and Cummings D.E. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annual review of medicine 2010, 61, 393-411.
  16. Jarolimova J., Tagoni J., and Stern T.A. Obesity: its epidemiology, comorbidities, and management. The primary care companion for CNS disorders 2013, 15 (5).
  17. Sugerman H.J., Londrey G.L., Kellum J.M., Wolf L., Liszka T., Engle K.M., Birkenhauer R., and Starkey J.V. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. The American journal of surgery 1989, 157 (1), 93-102.
  18. Prachand V.N., DaVee R.T., and Alverdy J.C. Duodenal switch provides superior weight loss in the super-obese (BMI≥ 50kg/m2) compared with gastric bypass. Annals of surgery 2006, 244 (4), 611.
  19. Magee C., Barry J., Brocklehurst J., Javed S., Macadam R., and Kerrigan D. Outcome of laparoscopic duodenal switch for morbid obesity. British Journal of Surgery 2011, 98 (1), 79-84.
  20. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., and Schoelles K. Bariatric surgery: a systematic review and meta-analysis. Jama 2004, 292 (14), 1724-1737.
  21. Afaneh C. and Pomp A.; Duodenal Switch: Technique and Outcomes, in The SAGES Manual of Bariatric Surgery 2018, Springer. p. 327-338.
  22. Prachand V.N. and Hussain M.; Duodenal Switch: Technique and Outcomes, in The ASMBS Textbook of Bariatric Surgery 2015, Springer. p. 211-220.
  23. S?vik T., Taha O., Aasheim E., Engstr?m M., Kristinsson J., Bj?rkman S., Schou C., L?nroth H., Mala T., and Olbers T. Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. British Journal of Surgery 2010, 97 (2), 160-166.
  24. Biertho L., Biron S., Hould F.-S., Lebel S., Marceau S., and Marceau P. Is biliopancreatic diversion with duodenal switch indicated for patients with body mass index< 50 kg/m2? Surgery for Obesity and Related Diseases 2010, 6 (5), 508-514.
  25. Anthone G.J., Lord R.V., DeMeester T.R., and Crookes P.F. The duodenal switch operation for the treatment of morbid obesity. Annals of surgery 2003, 238 (4), 618.
  26. Anderson B., Gill R.S., de Gara C.J., Karmali S., and Gagner M. Biliopancreatic diversion: the effectiveness of duodenal switch and its limitations. Gastroenterology research and practice 2013, 2013.
  27. Prachand V.N., Ward M., and Alverdy J.C. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight Loss in the super-obese (BMI≥ 50 kg/m 2) compared with gastric bypass. Journal of gastrointestinal surgery 2010, 14 (2), 211-220.
  28. Marceau P., Biron S., Hould F.-S., Lebel S., Marceau S., Lescelleur O., Biertho L., and Simard S. Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surgery for Obesity and Related Diseases 2009, 5 (1), 43-47.
  29. Dapri G., Cadi?re G.B., and Himpens J. Superobese and super-superobese patients: 2-step laparoscopic duodenal switch. Surgery for Obesity and Related Diseases 2011, 7 (6), 703-708.
  30. Dorman R.B., Rasmus N.F., Al-Haddad B.J., Serrot F.J., Slusarek B.M., Sampson B.K., Buchwald H., Leslie D.B., and Ikramuddin S. Benefits and complications of the duodenal switch/biliopancreatic diversion compared to the Roux-en-Y gastric bypass. Surgery 2012, 152 (4), 758-767.
  31. Hedberg J. and Sundbom M. Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass?a randomized controlled trial. Surgery for Obesity and Related Diseases 2012, 8 (3), 338-343.
  32. Scopinaro N., Marinari G.M., Camerini G.B., Papadia F.S., and Adami G.F. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes care 2005, 28 (10), 2406-2411.
  33. Pories W.J., Swanson M.S., MacDonald K.G., Long S.B., Morris P.G., Brown B.M., Barakat H.A., DeRamon R.A., Israel G., and Dolezal J.M. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Annals of surgery 1995, 222 (3), 339.
  34. Hussain M. and Pomp A. Biliopancreatic diversion with duodenal switch in the treatment of diabetes: an argument that a chance to cut is a chance to cure. Canadian Journal of Diabetes 2011, 35 (2), 109-114.
  35. Mingrone G., Panunzi S., De Gaetano A., Guidone C., Iaconelli A., Leccesi L., Nanni G., Pomp A., Castagneto M., and Ghirlanda G. Bariatric surgery versus conventional medical therapy for type 2 diabetes. New England Journal of Medicine 2012, 366 (17), 1577-1585.
  36. Iaconelli A., Panunzi S., De Gaetano A., Manco M., Guidone C., Leccesi L., Gniuli D., Nanni G., Castagneto M., and Ghirlanda G. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes care 2011, 34 (3), 561-567.
  37. Tsoli M., Chronaiou A., Kehagias I., Kalfarentzos F., and Alexandrides T.K. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surgery for Obesity and Related Diseases 2013, 9 (5), 667-677.
  38. Astiarraga B., Gastaldelli A., Muscelli E., Baldi S., Camastra S., Mari A., Papadia F., Camerini G., Adami G., and Scopinaro N. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. The Journal of Clinical Endocrinology & Metabolism 2013, 98 (7), 2765-2773.
  39. Kerrigan D.D., Leuratti L., Khwaja H.A., and Harper C.E.; Laparoscopic Biliopancreatic Diversion with Duodenal Switch (BPD-DS) Surgery, in Obesity, Bariatric and Metabolic Surgery 2016, Springer. p. 425-435.
  40. Khwaja H.A., Stewart D.J., Magee C.J., Javed S.M., and Kerrigan D.D. Petersen hernia complicating laparoscopic duodenal switch. Surgery for Obesity and Related Diseases 2012, 8 (2), 236-238.
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.